Project Details
Professor Dr. Thomas Winkler
Address
Friedrich-Alexander-Universität Erlangen-Nürnberg
Nikolaus-Fiebiger-Zentrum für Molekulare Medizin
Lehrstuhl für Genetik
Glückstraße 6
91054 Erlangen
-
As Applicant
-
Current projects
-
Completed projects
-
Zentrale Mittel und Koordinationsmittel (Research Units)
-
Regulation der allelen Exklusion in B-Lymphozyten Vorläuferzellen (Research Units)
-
Current projects
-
As Leader
-
Completed projects
-
Hochdurchsatz-Sequenziergerät (Major Research Instrumentation)
-
-
Completed projects
-
As Spokesperson
-
Completed projects
-
FOR 832: Regulators of the Humoral Immune Response (Research Units)
-
-
Completed projects
-
As Participating Researcher
-
Current projects
-
GRK 2599: FAIR - Fine-Tuners of the Adaptive Immune Response (Research Training Groups)
-
-
Completed projects
-
GRK 592: Lymphocytes: Differentiation, Activation and Deviation (Research Training Groups)
-
GRK 1071: Viruses of the Immune System (Research Training Groups)
-
GRK 1660: Key Signals of Adaptive Immune Response (Research Training Groups)
-
-
Current projects
-
As Project Head
-
Current projects
-
Dysregulation of the B-lymphocyte compartment leading to chronic GvHD (CRC/Transregios)
-
Animal engineering and complex transplantation models (CRC/Transregios)
-
-
Completed projects
-
Bedeutung von anti-dsDNA-Antikörpern für die Pathogenese der Lupusnephritis (Collaborative Research Centres)
-
Die Rolle von natürlichen IgM-Antikörpern und Komplement für die B-Zell-Toleranz gegenüber DNA (Collaborative Research Centres)
-
Molecular mechanisms of glomerular deposition of autoantibodies and their role in the pathogenesis of lupus nephritis (Collaborative Research Centres)
-
Genetically modified mice (Collaborative Research Centres)
-
Adoptive transfer of Cytomegalovirus-specific memory B cells: Mechnisms of protection (Collaborative Research Centres)
-
Adoptive Transfer of cytomegalovirus-specific memory B-cells: Implementation of a Phase I/IIa clinical study (Collaborative Research Centres)
-
Evolution of anti-DNA autoantibodies by somatic hypermutation (CRC/Transregios)
-
Transgenic mouse unit (CRC/Transregios)
-
-
Current projects